South Africa
· Delayed Price · Currency is ZAR · Price in ZAc Aspen Pharmacare Holdings Company Description
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide.
It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names.
It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names.
In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products.
Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
| Country | South Africa |
| Founded | 1850 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9,350 |
| CEO | Stephen Saad |
Contact Details
Address: Aspen Place Durban South Africa | |
| Phone | 27 31 580 8600 |
| Website | aspenpharma.com |
Stock Details
| Ticker Symbol | APN |
| Exchange | Johannesburg Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | ZAR |
| ISIN Number | ZAE000066692 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Stephen Saad | Chief Executive Officer |
| Sean Capazorio | Chief Financial Officer |
| Lorraine Hill | Chief Operating Officer |
| Sibongakonke Nkosi | Head of Investor Relations |